Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Arch Venture Corp > Profile

Instuitional Investor - Arch Venture Corp

Fund Profile
Filing Period:
Fund Name: Arch Venture Corp
Portfolio Value $1,100,261,770
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Parabilis Medicines Inc
 6,412,780 $175,517,789 15.95%
2.
Beam Therapeutics Inc.
 BEAM 4,540,132 $155,771,929 14.16%
3.
Rapport Therapeutics Inc.
 RAPP 3,728,738 $155,376,512 14.12%
4.
Seaport Therapeutics Inc
 6,294,951 $136,600,437 12.42%
5.
Erasca Inc.
 ERAS 7,091,557 $129,917,324 11.81%
Insider Monkey Quarterly Strategy
+599.2% Insider Monkey Quarterly Strategy
+227% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
500%
250%
0%

Returns since its inception in May 2014 (through June 2, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.

Past performance does not guarantee future returns. Click to see how the portfolio is constructed.